LMP2A-Specific Cytotoxic T Lymphocytes
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Allogeneic Lymphocytes -> LMP2A-Specific Cytotoxic T Lymphocytes
LMP2A-Specific Cytotoxic T Lymphocytes Definition
A preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP2A), with potential antineoplastic activity. T-lymphocytes are exposed ex vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP2A. These LMP2A-specific CTLs are subsequently exposed to EBV infected cells transfected with adenovirus encoding LMP2A, thereby further stimulating CTLs. Administered into patients with EBV-positive tumors, LMP2A-specific CTLs target LMPA-positive cells, resulting in cell lysis and inhibition of cancer cell proliferation. EBV LMP2A is expressed in various EBV-positive malignancies, including nasopharyngeal carcinoma and EBV-positive Hodgkin's and non-Hodgkin's lymphomas.
LMP2A-Specific Cytotoxic T Lymphocytes Synonyms
LMP2A-Specific Cytotoxic T-Lymphocytes, EBV-Specific Cytotoxic T-Lymphocytes, LMP2A-Specific CTL
Terms in LMP2A-Specific Cytotoxic T Lymphocytes category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.